NeuBase Therapeutics shares are trading higher after Symetryx Corporation acquired a 20% stake in the company and urged the board to issue a special $1 per share dividend.
Portfolio Pulse from Benzinga Newsdesk
Symetryx Corporation has acquired a 20% stake in NeuBase Therapeutics and urged the board to issue a special $1 per share dividend. Meanwhile, Southwest Airlines expects Q3 operating revenue per available seat mile to be down 5%-7% year over year, compared to prior guidance of down 3%-7%. The company also sees Q3 available seat miles up about 12%, unchanged from previous guidance.
September 06, 2023 | 4:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Southwest Airlines expects Q3 operating revenue per available seat mile to be down 5%-7% year over year, compared to prior guidance of down 3%-7%. The company also sees Q3 available seat miles up about 12%, unchanged from previous guidance.
The downward revision of Q3 operating revenue per available seat mile could negatively impact Southwest Airlines' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Symetryx Corporation has acquired a 20% stake in NeuBase Therapeutics and urged the board to issue a special $1 per share dividend.
The acquisition by Symetryx Corporation and the urging for a special dividend could potentially increase the value of NeuBase Therapeutics' shares in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100